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Crack-heroin speedball injection and its implications  






Background We report on an exploratory qualitative study investigating drug injectors’ 
narratives of vein damage and groin (femoral vein) injection associated with the injection 
of crack-heroin speedball. Methods We undertook 44 in-depth qualitative interviews 
among injectors of crack-heroin speedball in Bristol and London, England, in 2006.  
Findings Data suggests an emerging culture of crack-based speedball injection. 
Injectors’ narratives link speedball injection with shifts towards groin injection articulated 
as an acceptable risk and not merely as a last resort in the face of increased vein 
deterioration associated with speedball. Accounts of vein damage linked to speedball 
emphasise ‘missed hits’ related to the local anaesthetic action of crack, the excess use 
of citric in the preparation of speedball injections, and ‘flushing’ when making a hit. We 
find that groin injection persists despite an awareness of health risks and medical 
complications. Conclusions We emphasise an urgent need for reviewing harm 
reduction in relation to vein care in the context of shifts to crack-based speedball 
injection, and the use of the femoral vein, among UK injectors. There is an additional 
need for interventions to promote safer groin and speedball injecting as well as to 
prevent transitions toward groin and crack injection. 
 





Evidence suggests increased prevalence of crack use, particularly crack injection, in the UK over 
the past decade [1-5]. In the early 1990s, a significant increase in the proportion of London 
injecting drug users (IDUs) who were also using crack or cocaine was noted, with 16% (85/534) 
reporting the use of crack cocaine in a six month period in 1990 rising to 59% (297/507) in 1993 
[4]. In this study, the proportions injecting crack at least once in the previous six months 
increased from 1% (3/531) in 1990 to 27% (132/493) in 1993. Surveys of IDUs in England a 
decade later indicate that 40% (381/952) inject crack in the previous four weeks, usually in 
combination with opiates [3]. In some UK metropolitan centres, almost three-quarters of IDUs 
are regular injectors of ‘speedball’ – the practice whereby crack and heroin are injected 
simultaneously [2,6]. In London, 53% of 428 recently initiated injectors had injected crack or 
cocaine in the last 12 months, usually as a speedball [7].  
 
While there are reports of crack injection outside the UK, these are among a minority of injectors 
[8-11]. Of 2,198 IDUs in a multi-city study of young injectors in the USA, 15% reported crack 
injection, usually in combination with opiates [11]. There is an established culture of ‘speedball’ 
injection in some North American settings, but invariably this is the combined injection of heroin 
and powder cocaine [13-15]. While research has established a pattern of crack smoking 
alongside heroin injection [11,16-18], reports of crack-based speedball injection are rare among 
IDUs internationally. Despite indication of shifts towards crack-based speedball injection in the 
UK [1,2,5], there is an absence of related qualitative research. 
 
A largely North American literature associates elevated health harm with cocaine and speedball 
injection [18-25], non-injected crack use among injectors [17,18,21, 26,27], and crack injection 
[11,12]. In England, there has been a recent rise in the estimated prevalence of HIV and 
hepatitis C virus (HCV), as well as bacterial infections, among injectors [1,6,7]. Odds of hepatitis 
HCV infection are elevated among injectors of crack and speedball compared with heroin 
injectors only, and this may in part relate to crack injection overlapping with vulnerable street-
based populations of IDUs [6]. There is a higher risk of abscesses and injection site infections 
among crack injectors [28], including compared to cocaine and cocaine-based speedball 
injectors [12]. There has also been a marked recent rise in the number of drug-related deaths 
linked with crack or cocaine use in England [29].  
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Studies have noted shifts towards groin (femoral vein) injection among UK injectors [3,30], an 
injection site linked with increased health risks [31-33]. A survey of IDUs in multiple locations in 
England found 45% of 952 IDUs to regularly groin inject, rising to 58% in some cities [3]. HCV 
infection is elevated in the UK among regular groin injectors and among those in unstable 
housing, and crack-based speedball injectors are both more likely to be regular groin injectors 
and to have unstable housing [3,6]. UK groin injectors are more likely than those who do not 
groin inject to report an open wound at injection sites and to have had deep vein thrombosis [3]. 
 
Methods 
In 2006, we undertook exploratory qualitative interviews with 44 crack-heroin injectors as part of 
a wider project undertaking video-recorded observations of injecting drug use and injecting 
environments [34,35]. The study aimed to describe crack-based speedball injection and its 
association with health risks from the perspectives of injectors with current or past experience of 
injecting crack-heroin speedball. 
Sampling 
The study comprised people who were current injectors who reported ever injecting crack-heroin 
speedball. We defined ‘current injecting drug use’ as injection in the previous four weeks. The 
study adopted purposive sampling to recruit a minimum quota of female IDUs, and was weighted 
towards recruiting injectors with current or recent (that is, last year) experience of unstable 
housing. We defined unstable housing as living in temporary accommodation hostels, 
experience of homelessness, and being of no fixed abode. Our interest in purposively weighting 
the sample in this way related to wider project interests in public injecting environments [34]. The 
study adopted an a priori target of 40 interviews and a fixed data collection period enabling 44 
interviews to be undertaken.  
 
Bristol (West England) and London (and in particular Lambeth, South London) were selected as 
the two research sites because both cities have well established heroin and crack markets [2], 
including the emergence of ‘speedball’ injecting (termed ‘snowball’ in Bristol). Having recently 
completed observations of injecting drug use in both sites, the research team had established 
field contacts [6]. Access was gained by the authors through snowballing through networks of 
drug injectors, and in Bristol recruitment was also facilitated via a community-based drug service 
and syringe exchange. We emphasise that this qualitative sample is not necessarily numerically 
representative of the population of crack-based speedball injectors in each of the cities.  
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Data collection and analysis 
In-depth interviews, facilitated by a topic guide designed to explore participants’ accounts, were 
the primary means of data collection. These focused on: current injecting practices; sites of 
injection; experience of crack and speedball injection; perceived associated health risks of crack 
and speedball injection (including vein damage and site infections); and drug injecting 
environments. Interviews were undertaken during mid-2006 in a variety of locations, including 
parks, cafes, streets, lent office space, and at a community-based drug service in Bristol. 
Interviews were undertaken with only interviewer and interviewee present. Interviews lasted 
between 40 and 90 minutes, and were tape recorded for verbatim transcription with informed 
consent. All interviews were undertaken by the authors. Participants were also asked to 
complete brief questions on core quantitative indicators on sample characteristics. Participants 
provided signed informed consent, and received a cash incentive of £20. There were no refusals 
to interview. Interviews were supplemented by field observations of ‘naturally occurring’ crack 
and speedball injection in a range of injecting environments, leading to approximately 25 hours 
of unedited video-recorded observations [35].  
 
All interviews were transcribed verbatim for coding and analysis. Once transcribed, interview 
data was categorised thematically, with the key areas of investigation reflected in the topic guide 
providing the overall framework for coding. Initial first-level coding was undertaken by two of the 
authors (TR and DB), with second-level coding serving to break down first-level categories into 
smaller units and sub-themes. Key first-level themes important for this analysis included: 
speedball effects; vein care; groin injecting; and groin risks. Data coding was undertaken without 
the aid of qualitative analysis computer software. 
Sample characteristics  
The sample comprised 44 IDUs, of whom 25 (57%) were recruited in Bristol and 19 (43%) in 
London. The median age was 33 years (range 23-53 years), and the median age at first injection 
19 years (range 13-35 years). Three quarters of the sample were male (n=34) and two out of 
three reported homelessness in the past 12 months (n=31). 
 
Participants had been injecting heroin for a median of 11 years (range 3-28 years), crack for a 
median of 7 years (<1-26 years), and crack-heroin speedball for a median of 7 years (range <1 -
23 years). Half were currently prescribed an opioid substitution treatment (n=23). In the past four 
weeks two thirds reported daily or more frequent injection (n=29) and outdoor injection (n=29); 
and near two-thirds (n=26) reported speedball as the drug type they had injected most 
frequently, with the remainder injecting heroin most frequently. Near two thirds had injected into 
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their groin (femoral vein) (n=27) in the past four weeks, with just under half reporting the groin as 




Our findings are consistent with indications of transitions in UK cities from the primary injection 
of heroin alone towards the simultaneous injection of heroin and crack as a speedball [2,3]. The 
addition of crack was rationalised as driven by a search for a “better high”. Prior to 
experimenting with speedball, most had experienced smoking crack alongside their heroin use, 
and the injection of heroin had become functional or “normal”, no longer providing a “buzz”. 
Speedball was said to introduce a new “euphoria”, the heights of which had not been 
experienced before (“Man, it was unbelievable”). Whereas heroin was described as “medicine”, 
crack had “drug” potential, including among those also combining their heroin injection with 
crack smoking:  
 
The reason I started taking the crack was because I wanted a high. I started injecting it 
with brown [heroin] because everyone around me was, and they all seemed to think it 
was better. So I am chucking a few rocks [crack] in with the brown now, like one or two, 
then two bags in. Two of each in a spoon. [#29, Male, 32 years]  
 
With crack-heroin speedball injection normative for most participants, and described as 
qualitatively distinct from the consecutive use or injecting of crack alongside heroin, our findings 
are suggestive of an emerging culture of speedball injection distinct from that associated with 
heroin. A key feature of accounts of speedball was not being able to do one without the other. 
Drug patterns were defined by doing both crack and heroin, and in a single shot. While 
reinforced through local heroin and crack markets converging (“The dealers don’t help either 
because they sell them together”), this extended to situations in which individuals would be in 
withdrawal with access to one drug but not the other:  
 
So it was always injecting them together. Some dealers will only have brown [heroin] and 
they’re waiting for the white [crack], and I won’t buy the brown because otherwise it just 
ends up in the pocket for ages and you run around frustrated cos you can’t have a dig. 
I’ve got to have both together. [#6, male, 46 years]  
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I don’t do one without the other. And it’s been like that for the last ten years. If I’m sick [in 
withdrawal] and I’ve got these [crack] in my pocket I won’t do it until I’ve made another 
tenner [ten pounds] to go with it. [#20, male, 33 years] 
Injectors’ accounts of the everyday health implications of speedball injection identified vein 
damage as a primary concern alongside that of transitions to groin (femoral) injection. We turn to 
these themes below. 
 
Vein damage 
Participants associated the crack in a speedball with the speeding up of deterioration to injecting 
sites. Crack, and the impurities within it, was said to “destroy” or “annihilate” veins, with crack 
causing damage to veins “quicker” than heroin alone: 
 
I’m trying not to snowball at the moment cos it seems to be making my veins collapse. 
There is bruising... Crack does destroy the veins anyway like, like the veins in my arms 
as well are really sore... When I’m just using gear it doesn’t seem to bruise the vein so 
much. [#3, male, 34 years] 
 
Crack associated vein damage was exacerbated by “missed hits”. These were common, and 
linked to the crack in speedballs acting as a local anaesthetic at the injection site. A missed hit 
was one which missed the vein, in part or in full, including an injection in which the needle slips 
out of the vein or even pierces through the vein, thus distributing some or all of the drug solute 
into surrounding tissue. As a consequence of the local anaesthetic action of crack, often the only 
indication injectors had of their speedball being a missed hit was that they did not “feel the 
effects” or when the injection site “lumps up” soon after injection: 
  
I can get a vein, and I’ll pull back the blood, and start pushing it in, and then maybe half 
way through it will decide to miss cos I’ve slightly moved. And then usually it lumps up, 
so I tend to realise… If you’ve shot the lot in, you only realise it’s a miss either when you 
see it lumping or when you realise there is no hit. [#9, male, 30 years] 
 
You won’t know that you’ve missed it. You just won’t get no buzz from it. And then the 
next day you’ll wake up and you’ll probably have a great big lump there [around the 
femoral vein], and won’t hardly be able to walk. Whereas if you’re missing with gear, you 
know straightway and you know to stop. [#7, male, 25 years] 
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For some with problems finding an injection site, or where injection sites had become painful, the 
anaesthetic properties of speedball enabled injection: 
 
If it’s just gear on it’s own, I’ll push it in and the pain is that unbearable I can’t push it in, 
whereas if I’ve got crack in there, I’ll push the first bit in, the pain will be, it’ll really hurt, 
but then the crack numbs it so I can push the rest in and it’s ok. But without the crack I 
wouldn’t be able to push it in, I’d be in trouble, I’d end up pulling the pin out, I can’t do it, 
it hurts so much. [#1, male, 31 years] 
 
Concern over missed hits increased the likelihood of “flushing” when making a speedball 
injection. This is the practice of repeatedly injecting the drug solute then drawing it back into the 
syringe before re-injecting it, usually as a precaution to ensure an injection had been successful, 
that it had not missed, and that venous blood had properly entered the syringe. Flushing was 
associated with the exacerbation of vein damage: “The more you flush, the more you kill your 
veins”:     
  
With the snowball you never know because when you inject, you put it in, draw it back, 
put it in again, and it numbs the pain, and it looks as if you are missing, and sometimes I 
can’t tell, so I am drawing it back to and forth. [#28, male, 28 years] 
 
Crack related vein damage was also linked by participants to citric powder, commonly used by 
injectors in both sites to break down the heroin and crack from base form to a solute when 
preparing a speedball: “I use citric, and citric fucks your veins really badly, that burns them”. 
There was uncertainty about how much citric to use, and how much more should be used when 
preparing speedball than heroin alone, with a rule-of-thumb to double the amount (“one for the 
brown, one for the white”). Speedball injectors may over compensate, using too much citric. As 
described by one injector when injecting speedball prepared by another: 
 
And you go “Oh you don’t need to put that much [citric] in”. And they go “Oh I always pus 
that amount in”. So then when you have a dig, you don’t miss, but you feel the citric and 
it burns. And you think that never happens when I do it, cos I only puts a little bit of citric 
in. [#6, male, 46 years] 
Groin injection 
Older, and longer-term, injectors tended to indicate that groin (femoral) injection was seen as a 
“last resort” as a consequence of vein damage. Such accounts are in keeping with a ‘linear 
progression’ description of transitions in injection sites:[3] arms, then hands, then legs, then 
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chest and feet to the groin and neck. For those having difficulty finding a vein, groin injection 
presented immediate relief, and once found, was generally used for as long as the vein held out.  
 
Findings suggest however, a shift towards using the groin as a primary site of injection, even 
when other sites remain accessible. In this respect, there was a clear demarcation in accounts 
between older more experienced injectors and younger less experienced injectors in their 
representations of the groin as an acceptable site of injection. Older IDUs depicted younger 
IDUs as accepting of groin injection out of preference rather than necessity:  
 
The young kids in Bristol that start using, they’ve got this huge thing, they go straight to 
the groin… And it’s insane. It’s fucking insane, man... That’s one of the worst places for it 
to go wrong, do you know what I mean? [#17, male, 26 years] 
 
The older generation… They see it [groin injection] as completely different to the younger 
generation, whereas the younger generation seem to think that is the right place to go 
there, it’s like the ‘in thing’. [#8, male, 31 years] 
 
Our findings show multiple reasons proffered by injectors for using the groin. First, being a larger 
vein with faster blood flow, injecting in the groin was described as a “better rush”, a “better 
feeling”, providing a “bigger and quicker” hit, and by some as the “best buzz in world”: 
 
People always want to know how to get the best hit. My mate suggested it because I was 
complaining about my arms… He said it was a quicker rush, that it was immediate. He 
said you get it quicker and feel it more. That’s why I use my groin. [#28, male 28 years] 
 
I know of people that could quite easily inject in their arms who have got massive veins in 
their arms, and they inject in their groin knowing that you do get a better hit from injecting 
in your groin. [#7, male, 27 years] 
 
Second, groin injection was described as discreet and convenient: “It’s easy and quick”; “I 
thought they were crazy, why risk losing a leg? But they said it was quick, simple and easy.”; 
“You can whosh, bang, in, whosh, bang, out”). Groin injection was therefore seen to go  “hand in 
hand” when injecting in public places and when under potential scrutiny from passers or the 
police: 
 
I started using my groin cos I was having all these problems [with veins] and that, and 
once you get your groin, and especially if you are homeless, you’re outside and that, I 
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mean there’s public walking about and that, so you want to be as quick as possible so 
no-one can see you… At the worst, if anyone sees you, it looks like you’re having a pee 
or something. Once you’ve got it, you just push it in, draw back. It’s so quick, it’s over in 
seconds. [#20, male, 33 years] 
 
Groin injecting is also discrete in the sense that injection track marks remain hidden from friends 
or family members: 
 
I’d go and see my parents I couldn’t ever like wear a T-shirt around the house. Now I can 
just like take my top off and lounge about and they don’t know any different. [#7, male, 25 
years] 
 
Mainly I groin inject. Not because I need to, but to be quite honest with you, I find it 
easier for one, and for two, it’s sort of like, it’s not on sight to my family who look at my 
arms and legs... I could be going elsewhere. [#8, male, 31 years] 
 
Lastly, the use of the groin was rationalised as relatively safe because it enabled a single 
injection and ‘sure shot’ without the need for repeated injection attempts in multiple sites, which 
might increase or sustain vein damage as well risk spreading bacterial infections. Groin injection 
was presented as an ‘acceptable risk’: 
 
The risks are outweighed by the fact that it’s quicker and a lot of times it’s safer. [How’s it 
safer?] Because like I said, when you use like, you know I’ve been six hours [trying to 
find a vein]. And that ain’t like in the same site, so I might, I’ve probably used about 15 
pins. And I’ve got all them dent marks on my leg, like all these marks. And each time I’ve 
attempted right, I’ve just run the risk of missing. [#6, male, 46 years] 
  
To begin with, you know, I had thought it was not so safe. But you know, because it’s an 
actual normal vein, I think, look at the overall picture, there’s not much difference really. If 
you’re going to get a clot, you’re going to get one you know, whether you inject in the 
arm, legs or groin. [#8, male, 31 years] 
 
Risk awareness and acceptability 
Injectors’ accounts at once associated groin injection with multiple health risks while rationalised 
the use of the groin as an acceptable risk given perceived situated benefits. Of immediate 
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concern was damage to the femoral vein. Finding the femoral vein was more difficult over time, 
requiring longer and longer needles, and increasingly painful injections: 
 
As far as I was concerned I could use it and use it and use it. And it would never end. Not 
realising when you batter a vein it sinks, and sometimes burns like mad, cos it’s telling 
you ain’t coming in here. [#9, male, 30 years] 
  
You end up pushing the vein back, you end up pushing it back and back… And now, I’m 
trying to get it, and I can’t find it. I have to stab it in to get it. Then I went onto long orange 
[longer needle] for a few months and it got to the point where I’d push it, it would go right 
through the vein, and I’d have to pull it out a bit to get the hit. [#7, male, 25 years] 
 
Difficulty hitting the femoral vein increased the chances of missing the hit, and importantly, 
accidentally hitting neighbouring femoral nerves or the artery, with potentially serious health 
consequences: 
 
I done it first in my arms and that’s when my mate said I should try the groin. After a few 
times, I started to get myself and I did it for a couple of years in the groin, and they just 
started going. I started hitting arteries, I was missing, hitting nerves. My legs went to 
pieces. I was in hospital three times. The last time, my legs were so bad, they just told 
me not to do it. [#29, male, 32 years] 
 
I know where they [femoral nerves] are now. I could be here [acts out injecting in right 
side of groin] or could move just a little touch and the blood could be lighter, and I push it 
in just 20 digits and it starts to go warm and tingly. That’s when I know I have hit a nerve. 
Actually, I did it five days ago. Just woke up, put it in, and the blood was like pink. I put 
10 digits in, I was half asleep but clucking [withdrawing]. It was constant bleeding and the 
pain was continuous. [#28, male, 28 years] 
 
As with speedball injection in general, the anaesthetic effects of crack on the injection site 
increased the chances of missing the femoral vein: “They won’t even know they are missing the 
vein because the crack is numbing the site. I think it has happened to me once or twice”. 
Awareness of having missed the femoral vein was said to be less immediate than when injecting 
into surface veins elsewhere on the body: “Go in your groin, and you don’t know if you’re 
missing”. The pain emanating from a missed groin hit into the artery or surrounding nerves was 
described as acute by all who had experienced it (almost all we interviewed), and likened to 
“setting fire” to one’s leg. For example: 
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I was in the toilet. I’ve pulled it back and I could see blood’s filled up. But it’s one of those 
ones with the ultra violet lights in, so you can’t see properly. So I just assumed it was in, 
just went, whacked in the whole lot, and just all of a sudden got this pain. And I just 
ripped the pin out my leg, and fucking just like bouncing around inside this cubicle trying 
to be quiet... Fucking painful. [#7, male, 25 years] 
 
One time, I clipped the artery and I nearly hit the fucking ceiling… See your tooth nerves, 
if you stick a pin in it hard, that is what the pain is like going into your nerve. [#31, male, 
39 years] 
 
Multiple complications were associated with groin injection, including deep vein thrombosis 
(DVT), septicaemia, and bacterial infections. Injectors spoke of having “multiple blood clots in 
both legs”, of fearing that “I’m going to loose my legs if I carry on”, of getting to a stage “where I 
couldn’t literally walk anymore”, and for one person we interviewed, having had a leg amputated.   
Yet the need to inject, and the greater certainty and ease the groin provides for a successful 
injection, means that groin injection persists in the face of heightened awareness of health risks 
as well as experience of missed hits and complications resulting from sustained groin injection: 
 
The pain [of hitting the artery] is so intense. Tears coming out my eyes. I’ve hit my nerve 
as well. Oh, I nearly jumped through the ceiling when I did that. The damage, it’s 
frightening. You’ve got to be so careful. So many, you know, intimate body parts in your 
groin. But you know, you carry on doing it. [#16, male, 32 years] 
 
When you see people who have lost their legs and stuff. You know the risk involved is 
DVT and blood clotting of arteries and circulation to the leg but you are desperate for a 
hit and your veins have run out in your arms and your ankles, and the only place you 
know where you can go is your groin. If you can get it once, you’ll go there. If it is bad, 
then you go there. It is scary. [#27, male, 43 years] 
 
It is dangerous like. It’s stupid. I have got blood clots. I have been in hospital for two 
weeks. When I started, I used the arms, but now I don’t really want to go there because I 
know the feeling is not as good. [#28, male, 28 years] 
We identified in injectors’ accounts five main strategies used to reduce risks associated with 
groin injecting. These included, first, seeking assistance from other injectors to help locate and 
administer an injection into the femoral vein. While some described this process as “hit and 
miss”, technique was said to usually improve through “trial and error”, once knowing “where it is 
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you are going”. Second, rotating injections between groins, once one side had become 
“overused”, “sore”, or if infections were suspected, though most we interviewed had a favoured 
or “good” side and were reluctant to shift sides once one had become regularly amenable to 
successful injection. Third, selecting an appropriate length needle to reach the vein without 
piercing through the vein entirely. Fourth, cleaning the injection site, though few we interviewed 
mentioned doing this routinely, and field observations showed that injectors rarely washed their 
hands prior to injection or swabbed injection sites [35]. And most commonly mentioned, 
checking the colour of the blood flushing into the syringe. Here, “dark blood” would indicate that 
the vein had been found, but “pink blood” would indicate that the injection was being made into 
an artery. However, this strategy was not failsafe, especially in low light conditions. As one 
injector describes of the difficulties of distinguishing venous from arterial blood flushing into the 
syringe: 
 
I felt the pressure all the way down my leg and felt my feet swelling up. Lots of pins and 
needles. I got blood back in the syringe. Sometimes it is hard to identify that. What you 
have to be careful of is the colour of the blood coming out. The vein is supposed to be 
darker than the artery in the book, because artery blood is pink. I normally squeeze a little 
bit of the hit in first to see if there is a little bit of pain and then I know there is not an artery. 
The reason I think I hit the artery was because I didn’t feel the hit. [#27, male, 43] 
 
Discussion 
This exploratory study emphasises a need for harm reduction services in the UK to target crack 
and speedball injectors to promote improved needle hygiene, vein care and safer groin injection. 
Three key hypotheses emerge from this study: that there is an emerging culture of crack-based 
speedball injection in some UK cities; that shifts towards crack injection introduce elevated levels 
of harm related to vein damage; and that there are shifts towards the ‘risk acceptability’ of groin 
injection. The generalisability of these hypotheses are inevitably limited to the samples and 
settings selected, with the focus of analyses being participant personal accounts of lived 
experience. Our findings thus warrant further substantiation via epidemiological studies of the 
extent and distribution of vein damage and related infections associated with crack-based 
speedball injection and of transitions towards groin injection. We also highlight the need for 
comparative research to assess the relative distribution of vein damage and injection site 
infections of cocaine-based and crack-based speedball injection. 
 
Findings suggest an emerging culture of crack-based speedball injection as distinct from opioid 
use and the consecutive use of crack and heroin, a hypothesis to some extent corroborated by 
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crack-based speedball injection becoming increasingly normative among UK injectors [2,5,6,36]. 
Clinical studies imply that the simultaneous administration of cocaine and opioids “does not 
induce a novel set of subjective effects” but instead “induces, simultaneously, effects that are 
typical to both drugs” which can be “more reinforcing than either drug alone” including especially 
when “low doses of heroin and cocaine are mixed” [15: 11-12]. Our study suggests that a ‘social 
pharmacology’ of drug effect [37] associated with crack and speedball injection distinguishes 
speedball as offering an enhanced drug effect over heroin alone, that is distinct from the 
consecutive use of crack and heroin, and which symbolically affords speedball greater 
hierarchical status as a ‘drug’ in a context of opioid dependency. Speedball was commonly 
characterised as ‘euphoric’, with transitions towards speedball injection largely rationalised as a 
search for a ‘better high’. Whereas heroin was characterised in functional terms as a ’medicine’ 
to prevent withdrawal and maintain normality, crack in a speedball was articulated as 
pleasurable, as provided the ‘high’.   
    
As elsewhere [12,28,38-39], we found that speedball injection, and crack specifically, is strongly 
associated by injectors with the rapid deterioration of veins at injection sites, and to related 
health harms including abscesses, cellulitis and other skin infections. It is important to note that 
increased reports of injection site infections in the UK have coincided with the changing 
epidemiology of injecting drug use towards crack injection [2]. Injectors associated vein damage 
with ‘missed hits’ resulting from crack anesthetising the injection site, but also as a direct effect 
of crack (and properties mixed with it). The use of citric powder in the preparation of speedball 
injections was also linked with vein damage. While there exists a small literature on the use of 
citric and other acids in the preparation of heroin injection [40-45], there is a lack of clinical 
literature assessing the optimum amounts of citric powder required to acidify crack relative to its 
weight and purity in a speedball. The amount of citric powder required to acidify crack in a 
speedball is, however, considerably more than that required when preparing heroin only 
injections, and perhaps in the order of two thirds of the weight of citric to the weight of crack, 
excluding impurities (Jenny Scott, personal communication, 2007). Although associated with 
less injecting related harms than other forms of citric, such as lemon juice, citric powder is a 
known irritant to vein tissue, and is associated with greater pain and burns at injecting sites than 
other acidifiers, such as vitamin C powder (ascorbic acid) [40,41]. Critic powder, however, is 
more commonly distributed than vitamin C powder by harm reduction projects in the UK, 
including in our study sites.  
 
In addition to citric powder, injectors associated ‘flushing’ with increased vein damage, a practice 
largely borne out of heightened awareness of the risk of missed hits, and in the context of groin 
injection, anxiety over accidentally hitting the femoral artery. While there is not a clinical literature 
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on the potential aggravation to veins caused by flushing when making injections, it is logical that 
repeated flushing of the drug solute could increase irritation to the vein lining and thereby also 
increase the risk of phlebitis (Jenny Scott, personal communication, 2007). These findings 
emphasise the need for UK drug services to place strong and specific emphasis on vein care 
among crack-based speedball injectors, including advice in relation to the use, amount and 
availability of acidifiers in preparing speedball injections.  
 
We found that groin injection may be considered an ‘acceptable risk’ given perceived situated 
benefits, particularly among younger speedball injectors, but that groin injection was also 
perceived to have come about as a result of the deterioration of veins, in part as a consequence 
of speedball injection. Aside from lack of other vein options, common reasons for groin injection 
included speed, ease, discretion, a better rush, and relative safety in comparison with injecting in 
previously damaged injection sites [3,30]. Most injectors seemed aware of the multiple health 
complications of groin injection and perceived it to have been a ‘risk boundary’ crossed. Long-
term use of the femoral vein may lead to vascular complications and circulatory problems such 
as deep vein thrombosis, leg ulcers and infections, in extreme cases resulting in leg amputation 
[32,33,46]. We found that most persisted with groin injection despite awareness of risk and 
despite having experienced medical complications or missed hits into the neighbouring femoral 
nerves or artery.  
 
Given the health risks associated with groin injection [32,33,46], we recognise that there is a 
need for balance in the extent to which safer groin injection should be promoted as harm 
reduction. However, our study emphasises that groin injection can be the norm among injectors, 
including younger less experienced injectors. With as many as half of UK injectors groin injecting 
[3], and with transitions to groin injection potentially intensified by vein deterioration associated 
with crack-based speedball injection, we identify an urgent need to provide UK injectors with 
harm reduction advice in relation to groin injection. 
 
In conclusion, we emphasise that shifts towards crack-based speedball injection in combination 
with shifts towards the risk acceptability of groin injection present major challenges to harm 
reduction services in the UK, which evolved primarily in response to heroin injection [47]. We 
emphasise the need to tailor harm reduction services to speedball injectors as a distinct sub-
group. There is a particular need to promote vein care and assist with the treatment to injecting 
site infections. The incorporation within harm reduction services of nurses specifically trained in 
treating injecting site wounds and infections would maximise opportunities for preventing long-
term medical complications associated with vein damage, as well as likely save costs associated 
with accident and emergency admissions [48,49]. Lastly, we identify a need to consider 
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interventions to encourage transitions among current crack-based speedball injectors towards 
crack smoking and interventions to help prevent transitions to groin injection through the 
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